The Maryland General Assembly’s 2025 legislative Session concluded with the enactment of many health care laws that will impact health care facilities, providers, insurers, and patients in the State. Here are some of the highlights from the 2025 Session. Artificial Intelligence A new law was enacted concerning the use of Artificial Intelligence (AI) by certain…Read More
Ozempic® is the band name of one of the increasingly available glucagon-like peptide-1 (GLP-1) receptor agonists, created to treat Type 2 diabetes but increasingly used to promote extreme weight loss. GLP-1s include semaglutide (brand names Ozempic®, Wegovy®, and Rybelsus®) and tirzepatide (brand names Monjaro® and Zepbound®), two drugs that, until recently, were on the Food…Read More
The explosive growth of artificial intelligence (AI) offers many opportunities to increase efficiency in health care delivery, allowing providers to focus more of their time on delivering quality care, but providers must thoughtfully navigate long standing privacy laws when deploying new technology. An increasingly common application of AI in the health care space is ambient…Read More
On November 12, 2024, the Federal Trade Commission (FTC) issued a new final rule on “Premerger Notification; Reporting and Waiting Period Requirement”. This rule (the New Rule) addresses areas the FTC identified as deficiencies under the current implementation of the Hart-Scott-Rodino Improvements Act of 1976 (HSR). HSR obligates premerger reporting requirements for parties in certain…Read More
In the last days of the Biden administration, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) issued updated compliance program guidance for nursing facilities for the first time in 16 years. The Nursing Facility Industry Segment-Specific Compliance Program Guidance (Program Guidance), while non-binding, provides critical insight into how the…Read More
On September 9, 2024, the Departments of Labor, Health and Human Services, and Treasury issued an updated Mental Health Parity final rule (Final Rule), setting forth new requirements for compliance with the Mental Health Parity and Addiction Equity Act (MHPAEA) as amended by the Consolidated Appropriations Act, 2021. MHPAEA requires large group health plans…Read More
Maryland is one of only two states, along with Vermont, launching the first cohort of the new Advancing All-Payer Health Equity Approaches and Development (AHEAD) total cost of care model which will begin next year following a planning period already underway. Maryland has experimented with various unique payment models for decades, most recently the Maryland…Read More
In 2022, the Maryland General Assembly passed The Climate Solutions Now Act (CSNA), which is one of the most ambitious examples of climate change legislation in the country. As a result of the CSNA, the Maryland Department of the Environment (MDE) was tasked with creating new regulations, requiring owners of certain large buildings (covered buildings)…Read More
On October 28, 2024, the federal appellate court for the Fifth Circuit, in Memorial Hermann Accountable Care Organization v. Commissioner, affirmed a United States Tax Court decision, which held that an Accountable Care Organization in the Medicare Shared Saving Program did not meet its burden of showing that it qualified for exemption from federal income tax…Read More
Maryland has become one of the most recent battleground states for litigation regarding the federal 340B drug program initiated by pharmaceutical companies looking to curb the discounts they argue have expanded far beyond the program’s original intent. The 340B Program The 340B program allows hospitals and other covered providers to purchase outpatient drugs from pharmaceutical…Read More